Emmanuelle Liaudet-Coopman
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 21, 2025
Cathepsins: Novel opportunities for antibody therapeutics in cancer.Timothée David, Pénélope Desroys du Roure, Aude Mallavialle
|Jan 12, 2025
Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy.Pénélope Desroys du Roure, Timothée David, Aude Mallavialle
|Nov 29, 2023
Anti-cathepsin D immunotherapy triggers both innate and adaptive anti-tumour immunity in breast cancer.Timothée David, Aude Mallavialle, Julien Faget
|Nov 08, 2022
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.Lindsay B Alcaraz, Aude Mallavialle, Caroline Mollevi
|Feb 06, 2019
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.Yahya Ashraf, Hanane Mansouri, Valérie Laurent-Matha
Pageof 1
Frequent Collaborators
4 joint publications
Thierry Chardès
2 joint publications
Aude Mallavialle
2 joint publications
Valérie Laurent-Matha
2 joint publications
Pascal Roger
2 joint publications
Séverine Guiu
1 joint publications
Lindsay B Alcaraz
1 joint publications
Caroline Mollevi
1 joint publications
William Jacot
1 joint publications
Andrei Turtoi
1 joint publications
Timothée David
